Neogen Reports 18% Increase in Net Income, 12% Increase i...(0% improvement of sales in the quarter o...)

Sales of veterinary products through over-the-counter distributor channels were led by strong increases in sales of products to treat wounds, and leg and foot conditions. The company's Ideal Instruments brand, including disposable needles and syringes, also had a solid quarter with sales growth of 11% compared to the previous year's first quarter.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases, and sanitation concerns, and dehydrated culture media. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.

    NEOGEN CORPORATION SUMMARIZED UNAUDITED CONSOLIDATED OPERATING DATA
    (In thousands, except for percentages and per share amounts)

                                             Quarter
                                         Ended Aug. 31
                                        2009      2008
                                        ----      ----
     Revenue
        Food Safety                  $17,476   $15,549
        Animal Safety                 14,871    13,256
                                      ------    ------
     Total revenue                    32,347    28,805
     Cost of sales                    15,077    14,001
                                      ------    ------
     Gross margin                     17,270    14,804
     Other expenses
        Sales & marketing              5,972     5,619
        Administrative                 2,890     2,580

'/>"/>
SOURCE  Neogen Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 
Related biology technology :

1. Neogen Acquires Kane Enterprises
2. Neogen Reports 25% Increase in Net Income, 13% Increase in Revenues
3. Neogen Acquires Assets of Rivard Instruments
4. Neogen Reports 34% Increase in Net Income, 23% Increase in Revenues
5. Neogen Launches Quickest Test Available for Tetracyclines in Milk
6. NeoGenomics Announces Results for the Fourth Quarter and Full Year FY 2007
7. Webcast Alert: Neogen Corporation Announces 3rd Quarter Results
8. Neogen Reports 34% Increase in Net Income, 20% Increase in Revenues
9. NeoGenomics Files Annual Report on Form 10-KSB with the SEC
10. NeoGenomics Schedules Its Q1 2008 Earnings Release for May 7, 2008
11. Neogen Forms Mexican Subsidiary